Patent Leaderboard
USPTO Patent Rankings Data through Sept 30, 2025
LP

Leonard G. Presta

Genentech: 125 patents #7 of 2,392Top 1%
Merck: 16 patents #667 of 9,382Top 8%
SCSchering: 15 patents #182 of 2,442Top 8%
COCompugen: 11 patents #24 of 181Top 15%
IBIgm Biosciences: 9 patents #3 of 16Top 20%
PMPierre Fabre Médicament: 5 patents #44 of 297Top 15%
PIPionyr Immunotherapeutics: 5 patents #1 of 14Top 8%
SRScripps Research: 4 patents #208 of 1,293Top 20%
ZYZymeworks: 3 patents #21 of 65Top 35%
INIntervet: 2 patents #101 of 311Top 35%
GSGilead Sciences: 2 patents #483 of 952Top 55%
SGSeattle Genetics: 1 patents #65 of 101Top 65%
CTCellerant Therapeutics: 1 patents #10 of 16Top 65%
XEXencor: 1 patents #72 of 104Top 70%
ZBZymeworks Bc: 1 patents #23 of 36Top 65%
SOSurrozen Operating: 1 patents #14 of 19Top 75%
ALAlector: 1 patents #25 of 34Top 75%
APAlexion Pharmaceuticals: 1 patents #110 of 226Top 50%
CACantargia Ab: 1 patents #12 of 16Top 75%
San Francisco, CA: #52 of 26,999 inventorsTop 1%
California: #464 of 386,348 inventorsTop 1%
Overall (All Time): #2,794 of 4,157,543Top 1%
216 Patents All Time

Issued Patents All Time

Showing 176–200 of 216 patents

Patent #TitleCo-InventorsDate
6333310 NGF variants Roman Urfer, John W. Winslow 2001-12-25
6329509 Anti-IgE antibodies Paula M. Jardieu 2001-12-11
6290957 Anti-IgE antibodies and method of improving polypeptides Henry B. Lowman, Paula M. Jardieu, John Lowe 2001-09-18
6242195 Methods for determining binding of an analyte to a receptor Esohe Ekinaduese Idusogie, Michael George Mulkerrin, Robert L. Shields 2001-06-05
6194551 Polypeptide variants Esohe Ekinaduese Idusogie, Michael George Mulkerrin 2001-02-27
6172213 Anti-IgE antibodies and method of improving polypeptides Henry B. Lowman, Paula M. Jardieu, John Lowe 2001-01-09
6153189 Human TRK receptors and neurotrophic factor inhibitors David Louis Shelton, Roman Ufer 2000-11-28
6133426 Humanized anti-IL-8 monoclonal antibodies Tania N. Gonzalez, Steven Leong 2000-10-17
6121022 Altered polypeptides with increased half-life Bradley R. Snedecor 2000-09-19
6117980 Humanized anti-IL-8 monoclonal antibodies Tania N. Gonzalez, Steven Leong 2000-09-12
6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production Terri Lynn Davis-Smyth, Helen Hsifei Chen, Napoleone Ferrara 2000-08-08
6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life Bradley R. Snedecor 2000-08-01
6054297 Humanized antibodies and methods for making them Paul Carter 2000-04-25
6037453 Immunoglobulin variants Paula M. Jardieu 2000-03-14
6037454 Humanized anti-CD11a antibodies Paula M. Jardieu 2000-03-14
6027927 Human trk receptors and neurotrophic factor inhibitors David Louis Shelton, Roman Urfer 2000-02-22
6025158 Nucleic acids encoding humanized anti-IL-8 monoclonal antibodies Tania N. Gonzalez, Steven Leong 2000-02-15
6025166 Human trk receptors and neurotrophic factor inhibitors David Louis Shelton, Roman Urfer 2000-02-15
5994514 Immunoglobulin variants Paula M. Jardieu 1999-11-30
5994511 Anti-IgE antibodies and methods of improving polypeptides Henry B. Lowman, Paula M. Jardieu, John Lowe 1999-11-30
5981480 Pantropic neurotrophic factors Roman Urfer, John W. Winslow 1999-11-09
5965709 IgE antagonists Paula M. Jardieu 1999-10-12
5952199 Chimeric receptors as inhibitors of vascular endothelial growth factor activity, and processes for their production Terri Lynn Davis-Smyth, Helen Hsifei Chen, Napoleone Ferrara 1999-09-14
5910574 Human trk receptors and neurotrophic factor inhibitors David Louis Shelton, Roman Urfer 1999-06-08
5877016 Human trk receptors and neurotrophic factor inhibitors David Louis Shelton, Roman Urfer 1999-03-02